TransMedics Group, Inc.
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $96.43
- 52-Week Range
- $60.11 – $156.00
- Market Cap
- $3.27B
- P/E (TTM)
- 25.62
- EPS (TTM)
- 3.67
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 5.93
- PEG Ratio
- 0.96
- Return on Equity
- 31.89%
- Return on Assets
- 4.39%
- Gross Margin
- 58.60%
- Operating Margin
- 11.88%
- Profit Margin
- 19.85%
- Current Ratio
- 4.53
- Debt/Equity
- 1.57
- Total Debt
- $866.90M
- Free Cash Flow
- $28.15M
- Revenue Growth
- 41.10%
- Earnings Growth
- -29.80%
- Enterprise Value
- $3.72B
Market Snapshot
About
TransMedics Group, Inc. is a medical technology company revolutionizing organ transplant therapy for end-stage organ failure patients. The company has developed the Organ Care System, a portable extracorporeal warm perfusion and assessment platform that maintains donor organs in a near-physiologic state outside the body.